Skip to content

Safety study of Coolif high frequency system after TKA

An exploratory study on the safety of a Coolif high-frequency system for prolonged pain after total knee arthroplasty

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs032230726
Enrollment
5
Registered
2024-03-21
Start date
2024-04-25
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prolonged knee Pain after TKA KeywordTotal Knee Arthroplasty, Prolonged knee Pain

Interventions

Initiate protocol treatment in patient who have had at least 50% pain relief with knee blocks Protocol treatment is for single use only. Name of study equipment: Electrosurgical unit for cautery, Cool

Sponsors

Kaneko Haruka
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1)Patients who are between 20 and 85 years of age at the time of consent. (2)Patients who have undergone total knee arthroplasty for knee osteoarthritis and have not yet removed. (3)Patients with prolonged pain in the knee joint for more than 24 weeks after TKA (4)Patients who have had insufficient response to pain treatment for knee joint pain with oral or topical medications such as NSAIDs, acetaminophen, weak opioids, pregabalin, steroids, etc. (5)Patients with at least 50% reduction in NRS for knee nerve blocks (superior medial, superior lateral, and inferior medial knee nerve) (6 weeks prior to protocol treatment) (6)Patients who have given their free written consent to participate in this study.

Exclusion criteria

Exclusion criteria: (1)Patients with arthritis such as pyogenic arthritis, gout, pseudogout, etc. (2)Patients with any kind of pre-existing neurological disease (diabetic peripheral neuropathy, arteriosclerosis obliterans,severe mental illness) (3)Patients with infectious diseases (4)Patients with blood coagulation disorder or using anticoagulants (5)Patients who have already received treatment with the study device. (6)Patients who use implantable cardiac pacemakers, automatic implantable cardioverter-defibrillators, etc. (7)Patients who are unable to answer the subjective evaluation questionnaire regarding pain due to cognitive impairment. (8)Patients whose participation in this study is deemed inappropriate by the investigators.

Design outcomes

Primary

MeasureTime frame
Changes in the skin around the artificial joint, presence or absence of sensory abnormalities

Secondary

MeasureTime frame
(1)Change in pain VAS values from baseline to 6 months after protocol treatment (JKOM category I) (2)Score change in total JKOM and KOOS5 and each subcategory from baseline to 6 months after protocol treatment (3)Score change in JKOM and KOOS over time before and after the above protocol treatment (up to 24 weeks) (4)Change in radiographs of the lower extremities before and after protocol treatment (change in perimetallic area) (5)Percentage change in Forgotten joint score 12 before and after protocol treatment

Contacts

Public ContactHaruka Kaneko

Juntendo University Hospital

harukago@juntendo.ac.jp+81-3-3813-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Sep 19, 2026